日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PSMC6 regulation of ovarian cancer cisplatin resistance unravels a new mode for proteasome targeting.

PSMC6 对卵巢癌顺铂耐药性的调控揭示了蛋白酶体靶向的新模式

Costantino Matteo, Mirra Luca, D'arcy Padraig, Corno Cristina, Carenini Nives, Corna Elisabetta, Gubat Johannes, Ciniselli Chiara M, Pratesi Pietro, Verderio Paolo, Linder Stig, Beretta Giovanni L, Perego Paola

Molecular targeting of the deubiquitinase USP14 to circumvent cisplatin resistance in ovarian carcinoma and identification of novel inhibitors

通过分子靶向去泛素化酶USP14来克服卵巢癌的顺铂耐药性并鉴定新型抑制剂

Corno, Cristina; Russo, Debora; Pignotti, Francesco; De Giorgi, Francesca; Penna, Ilaria; Saccoliti, Francesco; Costantino, Matteo; Mirra, Luca; Pettinari, Pietro; Carenini, Nives; Corna, Elisabetta; Perta, Nunzio; Ciniselli, Chiara M; Pratesi, Pietro; Scarpelli, Rita; Bertozzi, Fabio; Verderio, Paolo; Beretta, Giovanni L; Di Muccio, Giovanni; Di Marino, Daniele; Bandiera, Tiziano; Perego, Paola

KiSS-1 Modulation by Epigenetic Agents Improves the Cisplatin Sensitivity of Lung Cancer Cells

表观遗传学方法调控KiSS-1可提高肺癌细胞对顺铂的敏感性

Beretta, Giovanni Luca; Alampi, Desirè; Corno, Cristina; Carenini, Nives; Corna, Elisabetta; Perego, Paola

Curcumin and Related Compounds in Cancer Cells: New Avenues for Old Molecules

姜黄素及相关化合物在癌细胞中的作用:旧分子的新用途

Costantino, Matteo; Corno, Cristina; Colombo, Diego; Perego, Paola

The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis

去泛素化酶USP8通过抑制细胞凋亡来调节卵巢癌细胞对顺铂的反应。

Corno, Cristina; D'Arcy, Padraig; Bagnoli, Marina; Paolini, Biagio; Costantino, Matteo; Carenini, Nives; Corna, Elisabetta; Alberti, Paola; Mezzanzanica, Delia; Colombo, Diego; Linder, Stig; Arrighetti, Noemi; Perego, Paola

Synergistic Effect of Perampanel and Temozolomide in Human Glioma Cell Lines

吡仑帕奈和替莫唑胺对人胶质瘤细胞系的协同作用

Salmaggi, Andrea; Corno, Cristina; Maschio, Marta; Donzelli, Sara; D'Urso, Annachiara; Perego, Paola; Ciusani, Emilio

Efficacy of a Selective Binder of α(V)β(3) Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models.

选择性结合α(V)β(3)整合素与酪氨酸激酶抑制剂舒尼替尼在卵巢癌临床前模型中的疗效

Sartori Andrea, Corno Cristina, De Cesare Michelandrea, Scanziani Eugenio, Minoli Lucia, Battistini Lucia, Zanardi Franca, Perego Paola